The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits

In a Perspective, Jacqueline Deeen discusses challenges in balancing the individual and population risks and benefits for CYD-TDV (Dengvaxia), the first available dengue vaccine.

Detalles Bibliográficos
Autor principal: Deen, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127493/
https://www.ncbi.nlm.nih.gov/pubmed/27898675
http://dx.doi.org/10.1371/journal.pmed.1002182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127493/
https://www.ncbi.nlm.nih.gov/pubmed/27898675
http://dx.doi.org/10.1371/journal.pmed.1002182

Ejemplares similares